Ardent Health Partners (NYSE:ARDT) Price Target Cut to $22.00 by Analysts at Morgan Stanley

Ardent Health Partners (NYSE:ARDT) had its price target decreased by equities research analysts at Morgan Stanley from $23.50 to $22.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price indicates a potential upside of 57.14% from the company’s current price.

A number of other research analysts also recently commented on ARDT. KeyCorp assumed coverage on shares of Ardent Health Partners in a research note on Friday, October 11th. They set an “overweight” rating and a $24.00 price objective on the stock. Leerink Partners boosted their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Royal Bank of Canada restated an “outperform” rating and set a $23.00 target price on shares of Ardent Health Partners in a report on Thursday, November 14th. Finally, Bank of America cut shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $21.55.

Ardent Health Partners Trading Down 0.7 %

ARDT traded down $0.10 on Tuesday, hitting $14.00. 147,542 shares of the company were exchanged, compared to its average volume of 267,605. Ardent Health Partners has a fifty-two week low of $13.63 and a fifty-two week high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The business has a fifty day moving average price of $16.22.

Hedge Funds Weigh In On Ardent Health Partners

Large investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets purchased a new stake in shares of Ardent Health Partners in the third quarter worth $42,000. Financial Management Professionals Inc. bought a new position in shares of Ardent Health Partners in the third quarter worth about $50,000. MetLife Investment Management LLC bought a new position in shares of Ardent Health Partners in the third quarter worth about $135,000. JPMorgan Chase & Co. bought a new position in shares of Ardent Health Partners in the third quarter worth about $154,000. Finally, Quadrature Capital Ltd purchased a new stake in shares of Ardent Health Partners during the third quarter worth about $229,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.